Cardiovascular Drugs and Therapy, Diabetes, Cardiovascular Risks, and Lipoproteins
In chemotherapy-induced cardiotoxicity and mitigation
Carmelita
Abrahams
Scholar“Research focused on Chemotherapy-induced cardiotoxicity and mitigation and adjacent fields.”
3
H-index
141
Citations
Carmelita has not officially claimed their profile. If you are Carmelita, claim it free.
Claim Your Profile
Pioneer
LOCKED

Pathfinder
LOCKED

Scholar
EARNED

Innovator
LOCKED

Inventor
LOCKED

Catalyst
LOCKED

Expert
UPGRADE
What I study
armelita Abrahams is a researcher working on Chemotherapy-induced cardiotoxicity and mitigation. A fuller summary will appear once they update their profile.
Publication output and reach
Carmelita's work has been cited 141 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Topics
Recent publications
3 worksExperimental and Molecular Pathology, Immune Response and Inflammation
Journal of Molecular and Cellular Cardiology Plus, Chemotherapy-induced cardiotoxicity and mitigation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Carmelita?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you